| Cancer Research UK Invests 10m Pounds In Drug Discovery
Cancer Research UK is investing 10m pounds in drug discovery projects at four universities across the UK.
Project leaders at Imperial College London, University of Oxford, University of Strathclyde and The School of Pharmacy in London will each receive £500k per year for five years to develop anti-cancer drugs.
The grants aim to encourage research into using small molecules to create new and targeted drugs to treat cancer. The projects will range from developing therapies for leukaemia to discovering new drugs to beat drug resistance in breast and prostate cancer treatments.
Professor Herbie Newell, Cancer Research UK's executive director of clinical and translational research, said: "We are in the process of significantly expanding our drug discovery programmes.
Focal Therapy Considered As Prostate Cancer Treatment
Gold Supplement is focused on a series of 12 peer-reviewed studies on the use of focal therapy in the treatment of prostate cancer.The studies were conducted by a group of leading urologists and radiologists led by David Bostwick, M.D., a pathologist specializing in urology, and Gary Onik, M.D., an interventional radiologist, both of whom served as co-editors of the supplement. This is the first published scientific compendium dedicated solely to focal prostate cancer treatment. One of the leading focal treatment methods is cryoablation, or the minimally invasive freezing of the cancerous tumors to destroy them.The studies presented in the supplement cover a broad range of issues related to focal therapy for prostate cancer including cancer volume; patient selection; biopsy techniques to adequately find and diagnose the extent of the cancer and the long-term effectiveness of focal treatments.In basic terms, focal therapy for prostate cancer, also known as "the male lumpectomy," is a new method of treating prostate cancer where the primary objective is to destroy the cancerous tissue in the prostate gland and avoid damaging the healthy tissue including the nerve bundles at the base of the gland that control potency and continence.
Independent MP Bill Casey of Nova Scotia to have surgery for prostate ...
AMHERST, N.S. - A Nova Scotia MP who was kicked out of the federal Conservative caucus for voting against the budget last year is undergoing treatment for prostate cancer. Bill Casey, who sits as an Independent in the House of Commons, is having surgery on Thursday. "The prognosis is that will eliminate the problem," he said Tuesday in an interview. "There may be some other treatments after that just to make sure." He said he expects to be off work for six weeks. Casey, 62, said the cancer was diagnosed during a routine blood test. He said he'd had no symptoms of prostate cancer and was caught by surprise when the tests and biopsies showed he would need the operation. He expects a full recovery and plans to resume his political career by April, including seeking re-election.
|
